State Street’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
OCA
PA
CC
RCM
EP
State Street's PALI Position: Q1 2026 in Review
State Street reduced its Palisade Bio (PALI) stake by 1.2% in Q1 2026, selling an estimated $14.2K and leaving 636,197 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3463.
State Street first reported a position in PALI in Q2 2014 and has held it in 16 quarters since. The position peaked at $2.75M in Q2 2014. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.
- State Street held 636,197 shares of Palisade Bio worth $1.11M as of Q1 2026.
- State Street sold 7,800 Palisade Bio shares in Q1 2026, an estimated $14.2K.
- Palisade Bio made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3463 holding.
- State Street first reported a position in Palisade Bio in Q2 2014 and has held it in 16 quarters since.
- State Street's Palisade Bio position peaked at $2.75M in Q2 2014.
- 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.